Every trade that managers of Identifai Genetics Limited disclose to ASX is tracked on this page. 3 insiders have disclosed 3 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of Identifai Genetics Limited for at least a year.
Across the 2,530 companies tracked on its exchange, the median is 3 filings; at 3 filings, this issuer sits right on that mark.
Source: insider filings from ASX. Past trades are no guide to future returns.
· cache
3 of 3 declarations
Identifai Genetics Limited is a company listed on the XASX, specializing in the field of genetics. It focuses on developing innovative solutions for genomic analysis.
Insider filings
Over the last 90 days, 3 filings published between 13 October and 16 October 2026: no open-market purchase or sale filed by an insider. 3 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)